The authors concluded that the range and variety of microalgae, as well as their antibacterial activity, could make them an important source of new antibiotics.
(PRWEB) June 25, 2015
Phycologia– Bacteria are resourceful, and their growing resistance to antibiotics has drawn attention and caused concern worldwide. There is an urgent need to find new sources of antibiotics. Among other options, scientists are turning to natural compounds from relatively unexplored microorganisms.
The authors of an article published in the current issue of the journal Phycologia looked at one such group of microorganisms: microalgae. Researchers have investigated only a few species so far, but work with freshwater microalgae collected from remote, scientifically unexplored regions in northern Canada has produced several promising candidates for antibiotics.
Microalgae are found everywhere: in lakes, rivers, garden ponds, even swimming pools. Yet little research has focused on them as potential antibiotics. Most antibiotics used today were created from bacteria, and the increasing resistance of the bacteria has prompted research into synthetic variations. The authors of the current article argue that microalgae may be another potential source of resistance-proof antibiotics.
The authors give an overview of some of the research on microorganisms as antibiotics. They focus on the antibacterial activity of cyanobacteria and eukaryotic unicellular algae, collectively referred to as microalgae. Screening programs are being used to search for potentially useful strains of these microalgae.
Researchers have found that microalgae can survive in and adapt to a range of harsh environmental conditions. Changes in temperature, light, pH, salinity, and the availability of nutrients have been extensively studied for their effects on microalgal growth. The adaptability of the microalgae suggests that they can develop resistance against a variety of stresses.
Microalgae also produce compounds that can stand up to the activity of some of the bacteria that sicken people. When their environment changes, these microorganisms produce even more antibacterial compounds. This makes them a potential resource in manufacturing antibiotic drugs. Advances in technologies that can detect, purify, and identify the antibacterial compounds produced by microalgae only increase the possibilities for new antibiotics.
The authors concluded that the range and variety of microalgae, as well as their antibacterial activity, could make them an important source of new antibiotics. Their ability to survive and adapt to a range of environments may be highly valuable to drug manufacturers. Still, there are no commercially available antibiotics from microalgae. More research is needed into these microorganisms to take advantage of this “untapped” source.
Full text of the article “Cyanobacteria and eukaryotic microalgae as potential sources of antibiotics,” Phycologia, Vol. 54, No. 3, 2014, is now available.
Phycologia is published bimonthly by the International Phycological Society and serves as a publishing medium for information about any aspect of phycology, basic or applied, including biochemistry, cell biology, developmental biology, ecology, evolution, genetics, molecular biology, physiology, and systematics. Learn more about the society at http://www.intphycsoc.org/.